AI & Big Data in Vaccines Market Research Report – Segmented By Deployment Mode (On-Premise, Cloud, and Hybrid); By End-User (Pharmaceuticals, Government Agencies, Healthcare Institutions, Research institutions, and Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. AI & Big Data in Vaccines Market – Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sour
1.5    Secondary Sources
Chapter 2. AI & Big Data in Vaccines Market – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
         2.3.1    Impact during 2023 – 2030
         2.3.2    Impact on Supply – Demand
Chapter 3. AI & Big Data in Vaccines Market – Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. AI & Big Data in Vaccines Market - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
         4.4.1     Bargaining Power of Suppliers
         4.4.2     Bargaining Powers of Customers
         4.4.3    Threat of New Entrants
         4.4.4    .Rivalry among Existing Players
         4.4.5    Threat of Substitutes
Chapter 5.AI & Big Data in Vaccines Market - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
Chapter 6.AI & Big Data in Vaccines Market - By Deployment Mode
6.1    On-Premise
6.2    Cloud
6.3    Hybrid
Chapter 7. AI & Big Data in Vaccines Market - By End-User
7.1    Pharmaceuticals
7.2    Government Agencies
7.3    Healthcare Institutions
7.4    Research Institutions
7.5    Others
Chapter 8. AI & Big Data in Vaccines Market – By Region
8.1    North America
8.2    Europe
8.3    Asia-Pacific
8.4    Latin America
8.5    The Middle East
8.6    Africa
Chapter 9. AI & Big Data in Vaccines Market – Key players
9.1    IBM Watson Health
9.2    Google Health
9.3    Microsoft
9.4    Oncora Medical
9.5    Caption Health
9.6    Butterfly Network
9.7    Corti
9.8    Babylon Health

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

The Global AI & Big Data in Vaccines Market was estimated to be worth USD 10.3 Billion in 2022 and is anticipated to reach a value of USD 117.81 Billion by 2030, growing at a fast CAGR of 35.61% during the forecast period 2023-2030.

Growing demand for healthcare analytics and increasing demand for efficient vaccine distribution are the market drivers for Global AI & Big Data in the Vaccines Market.

On-Premise, Cloud, and Hybrid are the segments under the Global AI & Big Data in Vaccines Market by deployment mode.

North America dominates the market for Global AI & Big Data in the Vaccines Market.

 

Asia-Pacific is the fastest-growing region in the Global AI & Big Data in Vaccines Market.